 |
 |
Date Announced: 29 Nov 2010
510 (k) Application Submitted to FDA.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging, announced today that it is exhibiting its CTLM system at the 96th RSNA 2010 Scientific Assembly and Annual Meeting, November 29th – December 2nd in Chicago, Illinois. The company is located at booth #4419 in Hall A of the North Building.
RSNA is the world's largest annual radiology meeting with more than 40,000 medical imaging members consisting of radiologist, radiation oncologists, medical physicists and allied scientists.
On November 22, 2010 the company submitted a Premarket Notification 510 (k) application to the Food and Drug Administration seeking United States marketing clearance for its CT Laser Breast imaging (CTLM) system.
Attendance for the 96th RSNA Scientific Assembly is expected to reach about 100,000 with medical professionals from all over the world and 650 healthcare companies exhibiting; remaining the top radiology exhibition in the U.S.
The CTLM system has received certification and licenses for the European CE marking, CMDCAS Canadian Health screening, China SFDA, UL, ISO 13485.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed the CTLM® system; a breast imaging device that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM®) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth.
Source: Imaging Diagnostic Systems
E-mail: see web site
Web Site: www.imds.com
| © 2024 SPIE Europe |
|
